Page 134 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

ADULT-ONSET ASTHMA – PREDICTORS OF CLINICAL COURSE AND SEVERITY
REFERENCES
1. Ronmark E, Lindberg A, Watson L, Lundback B. Outcome and severity of adult onset asthma - Report from the obstruc ve lung disease in northern Sweden studies (OLIN). Respiratory Medicine 2007; 101(11):2370-7.
2. Amelink M, de Nijs SB, de Groot JC, van Tilburg PMB, van Spiegel PI, Krouwels FH et al. Three phenotypes of adult-onset asthma. Allergy 2013; 68(5):674-80.
3. Amelink M, de Groot JC, de Nijs SB, Lu er R, Zwinderman AH, Sterk PJ et al. Severe adult-onset asthma: A dis nct phenotype. J Allergy Clin Immunol 2013; 132(2):336-41.
4. Moore WC, Bleecker ER, Curran-Evere D, Erzurum SC, Ameredes BT, Bacharier L et al. Characteriza on of the severe asthma phenotype by the Na onal Heart, Lung, and Blood Ins tute’s Severe Asthma Research Program. Journal of Allergy and Clinical Immunology 2007; 119(2):405-13.
5. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Dis nguishing severe asthma phenotypes: Role of age at onset and eosinophilic in amma on. Journal of Allergy and Clinical Immunology 2004; 113(1):101-8.
6. Amelink M, de Nijs SB, Berger M, Weersink EJ, ten Brinke A, Sterk PJ et al. Non-atopic males with adult onset asthma are at risk of persistent air ow limita on. Clinical and Experimental Allergy 2012; 42(5):769-74.
7. ten Brinke A, van Dissel JT, Sterk PJ, Zwinderman AH, Rabe KF, Bel EH. Persistent air ow limita on in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infec on. Journal of Allergy and Clinical Immunology 2001; 107(3):449-54.
8. Haahtela T, Tamminen K, Kava T, Malmberg LP, Ry la P, Nikander K et al. Thirteen-year follow-up of early interven on with an inhaled cor costeroid in pa ents with asthma. Journal of Allergy and Clinical Immunology 2009; 124(6):1180-5.
9. Global Ini a ve for Asthma (GINA). Global Strategy for Asthma Management and Preven on 2012 (update). 2012. Ref Type: Online Source
10. Juniper EF, O’Byrne PM, Guya GH, Ferrie PJ, King DR. Development and valida on of a ques onnaire to measure asthma control. European Respiratory Journal 1999; 14(4):902-7.
11. Hopkins C, Gille S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology 2009; 34(5):447-54.
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. Standardisa on of spirometry. European Respiratory Journal 2005; 26(2):319-38.
13. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO et al. An O cial ATS Clinical Prac ce Guideline: Interpreta on of Exhaled Nitric Oxide Levels (FENO) for Clinical Applica ons. American Journal of Respiratory and Cri cal Care Medicine 2011; 184(5):602-15.
14. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P et al. Sputum induc on. Eur Respir J Suppl 2002; 37:3s-8s.
15. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. EPOS 2012: European posi on paper on rhinosinusi s and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50(1):1-12.
16. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology 1993; 31(4):183-4.
17. Global Ini a ve for Asthma. Global Strategy for Asthma Management and Preven on. 2002. Ref Type: Online Source
132